(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.

Slides:



Advertisements
Similar presentations
Comparing different treatments How can we decide?.
Advertisements

1 Could there be a single European EQ tariff? Jan J.V. Busschbach, Ph.D. Former address: –iMTA, Erasmus university Present address: –Medical Psychology.
COCOM Kwaliteit van leven in maat en getal Jan van Busschbach.
Improving Psychological Care After Stroke
Justice and Economic Evaluation Prof. Dr. Jan Busschbach
1 The Future of Quality of Life Assessment in Cost-Effectiveness Research Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
All Parties Parliamentary Group for Diabetes Type 2 Diabetes: The role of Physical Activity/Exercise Dr. Silvano Zanuso, Ph.D University of Padua Technogym.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence November–December 2014.
1 Does it make a difference for the patient? Survival & Quality of life  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and.
1 A Health Economic View on Borderline Personality Disorder Prof. dr. Jan Busschbach Viersprong Institute for studies on Personality Disorders Medical.
Big Q and Little Q revisited Christopher McCabe PhD Capital Health Endowed Research Chair in Emergency Medicine Research.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Prof. dr. Jan van Busschbach Department of Medical Psychology & Psychotherapy Erasmus MC.
The Cost-Effectiveness of Providing DAFNE to Subgroups of Predicted Responders J Kruger 1, A Brennan 1, P Thokala 1, S Heller 2 on behalf of the DAFNE.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
The Importance of Decision Analytic Modelling in Evaluating Health Care Interventions Mark Sculpher Professor of Health Economics Centre for Health Economics.
Decision Analysis as a Basis for Estimating Cost- Effectiveness: The Experience of the National Institute for Health and Clinical Excellence in the UK.
Treatment Based Classification of the Spine- An Evidence Based Journey for the Physical Therapist Tara J. Manal, PT, DPT, OCS, SCS Gregory E. Hicks, PT,
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review Journal club presentation
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
1 Cost-effectiveness in Personality Disorder Dr. J.J.V. Busschbach Psychotherapeutic centre ‘De Viersprong’ –PO Box AA Halsteren
Overview of the EQ-5D Purpose and origins of the descriptive system.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
Is healthcare any good for patients? Measuring health outcomes using EQ-5D Professor Paul Kind Principal Investigator Outcomes Research Group Centre for.
Rescuing Clinical Trial Data For Economic Evaluation
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 4: Measuring costs - Part 1 Sept 15,
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
1 Reconciliation of Economic Arguments and Clinical Practice Monday November 4, 2002 ISPOR, Rotterdam Jan Busschbach PhD, –Department of Medical Psychology.
The Effectiveness of Psychodynamic Therapy and Cognitive Behavior Therapy in the Treatment of Personality Disorders: A Meta-Analysis. By Falk Leichsenring,
1 Patient values or values from the general public.
1 Monitoring Quality of Life in the Clinic Prof. dr. Jan van Busschbach Medical Psychology and Psychotherapy Erasmus MC.
1 The valuation of disease-specific health states to facilitate economic evaluation E. Kok, E. Stolk, Jan J. v. Busschbach Address: –Jan v. Busschbach.
Cost-effectiveness of psychotherapy for personality disorders Djøra Soeteman Viersprong Institute for Studies on Personality Disorders Erasmus Medical.
Validation / citations. Validation u Expert review of model structure u Expert review of basic code implementation u Reproduce original inputs u Correctly.
Decision Analysis Dr M G Dawes Centre for Evidence Based Medicine.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 Cost effectiveness as argument for reimbursement in prevention Jan J. v. Busschbach, Ph.D. Erasmus MC –Institute for Medical Psychology and Psychotherapy.
1 Interactive introduction in Quality of life Assessment Jan J. v. Busschbach, Ph.D. Department of Medical Psychology and Psychotherapy, Erasmus MC
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
Governance and Public Policy: a NICE example John Brazier Professor of Health Economics, ScHARR, University of Sheffield, UK With thanks to Matt Stevenson.
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
1 The Economic Burden of Personality Disorders  Djøra Soeteman, Jan J.V. Busschbach, Leona Hakkaart-van Roijen, Roel Verheul  Viersprong Institute for.
HEALTH ECONOMICS/PHARMACOECONOMICS FOR NON- HEALTH ECONOMISTS INTRODUCTION Elhem Sbaa Keyrus Biopharma.
Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy Viersprong.
11 Cost Effectiveness in Preventing Crime  Jan van Busschbach, Djøra Soeteman  Viersprong Institute for studies on Personality Disorders VISPD  Erasmus.
Treatment selection in patients with personality disorders: The role of patient characteristics Helene Andrea Janine van Manen, Anna Bartak, Jan van Busschbach,
1 The Cost Effectiveness of Treatment of Personality Disorder  Dr. Jan J.V. Busschbach  PTC De Viersprong, Erasmus MC, Rotterdam, 
Cost-Effectiveness of Psychotherapy for Personality Disorders Soeteman, Busschbach, Verheul.
Cost-effectiveness in the quest to convince the outside world Dr. Jan Busschbach De Viersprong Erasmus MC
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
1 The Economics of Health Care and New Technologies Friday October 18, 2002 Between Technology and Humanity, Brussels Jan Busschbach PhD, –Department of.
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Cost-Effectiveness of Psychotherapy (for Personality Disorders) Prof. dr. Jan van Busschbach.
Values Lower Than Death Jan J. v. Busschbach, Ph.D. –Erasmus University Rotterdam institute for Medical Technology Assessment (iMTA) PO box DR.
1 Quality of life and Cost-Effectiveness An Interactive Introduction Prof. Jan J. v. Busschbach, Ph.D. Erasmus MC Medical Psychology and Psychotherapy.
Who is involved in making NICE guidance recommendations and what evidence do they look at? Heidi Livingstone, Senior Public Involvement Adviser.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
Efficacy and cost-effectiveness of Acceptance and Commitment Therapy and a Workplace Intervention for workers on sickness absence due to mental disorders.
1 Utilization of Quality of Life Research in Decision-Making and Policy  Prof. Dr. Jan J.V. Busschbach  Erasmus MC, Rotterdam, The Netherlands  Section.
The burden of disease in patients with personality disorder indicated for psychotherapy: Arguments for necessity of care Djøra Soeteman, MSc
How useful is a reminder system in collection of follow-up quality of life data in clinical trials? Dr Shona Fielding.
The valuation of disease-specific questionnaires for QALY analysis
Justification treatment cost
Measuring outcomes Emma Frew October 2012.
Presentation transcript:

(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy Erasmus MC PO Box CA Rotterdam (direct: )

An different mindset: Comparing “dosages”  Usually... –Comparison between theoretical orientation of therapy  Typically... –Amount of therapy is keep constant  This assumes... –amount of therapy is relevant  Little differences –Nonspecific factors seems to drive treatment success  Amount of therapy relates to costs  Yet... –Relation between costs and effects is rarely investigated

SCEPTRE  Study on Cost-Effectiveness of Personality Disorder Treatment  Start: March 2003  6 clinics

SCEPTRE  About 900 patient with PD  Followed over 3 years  Dosages compared –Outpatient, day-hospital and inpatient psychotherapy –Shorter than or equal to 6 months, longer than 6 months  Clusters –A; N = 58 –B; N = 241 –C; N = 466  Naturalistic design

In need of a super covariate  Question to clinician: –“What are the important variables for treatment allocation?”  Answer: –“Everything is important!”  How to control for everything? –“We are in need of a super covariate”

Correction for selection bias  Propensity score –A sophisticated co-variance analysis –Combines several co-variates –To correct for baseline differences  If successful –Results can be interpreted as an RCT  Several checks on validity  Often used in –(health) economics –Epidemiology

Super Covariate: the propensity score  Age  Sex  Diagnosis (SIDP-IV)  Baseline GSI  Motivation  Measures of pathology –DAPP-BQ; SIPP; OQ-45  Quality of life (EQ-5D)

Can super covariate fly? Separate PhD, 2010 Medical Care, 2010 Psychotherapy and Psychosomatics, 2009

Cluster A: one of the largest studies ever Bartak, et al. Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster A personality disorder. Accepted for publication Psychotherapy and Psychosomatics

But assumptions are not met in cluster A

Assumptions met in:  3 groups in cluster B –Inpatient –Day-hospital –Outpatient  5 groups in cluster C –Short-term inpatient –Long-term inpatient –Short-term day-hospital –Long-term day-hospital –Long-term out-patient

Results cluster B Bartak et al. Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorder. Psychotherapy and Psychosomatics, in press

But no significant results in cluster B…  Differences diminish till P = 0.06 –After correction with the propensity score –Complicates conclusions  Assumptions of propensity score are met –Effect are reduces after correction  But costs could make the difference…

Results cluster C

Corrected rsults C GSI - Difference score Treatment group Long outpatient Short day hospital Long day hospital Short inpatient Short day hospital Long day hospital Short inpatient **0.4313** Long inpatient * * p < 0.05 ** p < 0.01 *** p < 0.001

Propensity escore in cluster C  Better effects of short-term inpatient psychotherapy remain significant  Assumptions propensity score are met –Results maintain  But costs could still make a difference…

Conclusions: effects  No comparison possible in cluster A –But psychotherapy seems to work –Inpatient / day hospital seems better  Non difference in B (after correction) –But costs can be decisive ….  Cluster C –Favorable results for short-term inpatient psychotherapy –Expect to dominates long in-patient –But is short-term inpatient worth the costs? Compared to long day hospital / short day hospital

QALY  Health economics addresses the efficient allocation of health care resources  For instance –Psychotherapy “long” versus “short” –“Psychotherapy in PD” versus “Care for diabetics”  Make effects comparable –Same effect parameter in diabetes as in PD  Survival and Quality of Life  Combined: Quality Adjusted Life Years (QALY)

19 QALY  Quality Adjusted Life Years  Area under the curve

20 EQ-5D  MOBILITY –I have no problems in walking about –I have some……. –I am confined to bed  SELF-CARE –I have no problems with self-care –I have some problems….. –I am unable…  USUAL ACTIVITIES –I have no problems with performing my usual activities –I have some problems… –I am unable….  PAIN/DISCOMFORT –I have no pain or discomfort –I have moderate ….. –I have extreme……..  ANXIETY/DEPRESSION –I am not anxious or depressed –I am moderately…….. –I am extremely….. The EuroQol EQ-5D is specially designed to measure the quality of life index for QALYs

21 Burden of disease: EQ-5D Soeteman et al. Journal of Personality Disorders, 2008;22: Soeteman et al. Psychiatric Services, 56, , 2005

Markov model Cluster B Soeteman et al. Cost-effectiveness of psychotherapy for cluster B personality disorders. British Journal of Psychiatry 2010;196:396–403.

Costs and effects in Cluster B Much difference Little difference

Cost per QALY

Costs and effects Cluster C 25 Soeteman et al. Cost-effectiveness of psychotherapy for cluster C personality disorders. Journal of Clinical Psychiatry (In Press)

Cost effectiveness Cluster C

Conclusion  Cost-effective treatment strategies are:  Cluster C PD: –Short-term inpatient psychotherapy (first choice) –Short-term day hospital psychotherapy –Sub-optimal treatment options are: Long-term day hospital and long-term inpatient  Cluster B PD: –Outpatient psychotherapy (first choice) –Day hospital psychotherapy –Sub-optimal treatment option is: Inpatient psychotherapy 27